Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosolized antibiotics: current and future.

G C Smaldone1, L B Palmer

  • 1Department of Medicine, State University of New York at Stony Brook, 11794-8172, USA. GSmaldone@mail.som.sunysb.edu

Respiratory Care
|July 14, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Global survey on nebulization of antimicrobial agents in mechanically ventilated patients: a call for international guidelines.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016
Same author

The Treatment of Syphilis.

Journal of the National Medical Association·2010
Same author

Major Surgery in the Home.

Journal of the National Medical Association·2010
Same author

Editor's Note.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same author

Consensus statement: aerosols and delivery devices.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009

Aerosolized antibiotics may prevent ventilator-associated pneumonia (VAP) in high-risk patients. Measuring airway secretions could identify susceptible individuals for targeted prophylactic therapy, potentially avoiding systemic complications.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Critical Care

Background:

  • Ventilator-associated pneumonia (VAP) is a significant concern in critically ill patients.
  • Current VAP prevention strategies have limitations.
  • Targeted therapies are needed to reduce VAP incidence and mortality.

Purpose of the Study:

  • To explore aerosolized antibiotic therapy as a targeted approach for VAP prevention.
  • To define a high-risk patient population susceptible to VAP.
  • To assess the potential of measuring airway secretions as a surrogate for identifying this population.

Main Methods:

  • Investigating aerosolized antibiotic delivery to the airways and deep lung.
  • Evaluating airway secretion volume as a marker for inflammation and infection.

Related Experiment Videos

  • Correlating high sputum volume with pathogenic organism growth and inflammatory cytokines.

    • Main Results:

    • Elevated airway secretion volume may indicate a high-risk state for VAP.
    • This volume correlates with increased pathogenic organisms and inflammatory markers.
    • Aerosolized antibiotics offer potential for targeted airway therapy.

    Conclusions:

    • Defining a high-risk population is crucial for the success of targeted VAP prevention.
    • Airway secretion volume may serve as a useful surrogate marker.
    • Further large-scale clinical trials are necessary to validate this approach and assess prophylactic efficacy.